ProfileGDS4718 / 210252_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 86% 86% 83% 88% 85% 83% 84% 86% 88% 85% 87% 86% 83% 81% 82% 83% 84% 83% 80% 76% 87% 85% 87% 86% 85% 83% 84% 87% 87% 85% 79% 79% 88% 87% 86% 79% 82% 84% 87% 84% 85% 83% 82% 83% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.6103286
GSM549102patient 115, normal, homogenized [OPG study]8.5755986
GSM549104patient 119, normal, homogenized [OPG study]8.2758283
GSM549108patient 138, normal, homogenized [OPG study]8.858588
GSM549119patient 077, normal, homogenized [OPG study]8.4738785
GSM549133patient 032, cancer, homogenized [OPG study]8.3746883
GSM549139patient 042, cancer, homogenized [OPG study]8.3343884
GSM549099patient 107, normal, homogenized [OPG study]8.4712586
GSM549109patient 139, normal, homogenized [OPG study]8.8516588
GSM549110patient 046, normal, homogenized [OPG study]8.3995485
GSM549114patient 063, normal, homogenized [OPG study]8.8255587
GSM549122patient 082, normal, homogenized [OPG study]8.6212586
GSM549134patient 033, cancer, homogenized [OPG study]8.2721283
GSM549136patient 036, cancer, homogenized [OPG study]8.0473581
GSM549140patient 044, cancer, homogenized [OPG study]8.1537482
GSM549111patient 047, normal, homogenized [OPG study]8.2639983
GSM549113patient 057, normal, homogenized [OPG study]8.5378984
GSM549132patient 031, cancer, homogenized [OPG study]8.1777183
GSM549137patient 038, cancer, homogenized [OPG study]7.9498780
GSM549142patient 047, cancer, homogenized [OPG study]7.3054476
GSM549100patient 110, normal, homogenized [OPG study]8.6822187
GSM549107patient 135, normal, homogenized [OPG study]8.4470785
GSM549115patient 068, normal, homogenized [OPG study]8.8709287
GSM549116patient 072, normal, homogenized [OPG study]8.6245986
GSM549120patient 078, normal, homogenized [OPG study]8.4643385
GSM549131patient 030, cancer, homogenized [OPG study]8.262883
GSM549118patient 074, normal, homogenized [OPG study]8.3929384
GSM549129patient 027, cancer, homogenized [OPG study]8.665787
GSM549123patient 088, normal, homogenized [OPG study]8.6995987
GSM549124patient 006, cancer, homogenized [OPG study]8.3095985
GSM549126patient 015, cancer, homogenized [OPG study]7.7393979
GSM549128patient 025, cancer, homogenized [OPG study]7.7949279
GSM549103patient 117, normal, homogenized [OPG study]8.8033888
GSM549117patient 073, normal, homogenized [OPG study]8.847187
GSM549138patient 041, cancer, homogenized [OPG study]8.6684786
GSM549141patient 045, cancer, homogenized [OPG study]7.928179
GSM549130patient 028, cancer, homogenized [OPG study]8.0141182
GSM549101patient 111, normal, homogenized [OPG study]8.3213584
GSM549105patient 128, normal, homogenized [OPG study]8.6610287
GSM549106patient 134, normal, homogenized [OPG study]8.5303584
GSM549112patient 048, normal, homogenized [OPG study]8.5185285
GSM549125patient 011, cancer, homogenized [OPG study]8.2010783
GSM549127patient 024, cancer, homogenized [OPG study]8.1347482
GSM549135patient 035, cancer, homogenized [OPG study]8.2962483